The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I, dose-finding study of orally administered S-1 in combination with epirubicin and oxaliplatin (EOS) in patients (pts) with advanced or metastatic gastrointestinal cancer (AGIC) and chemonaïve advanced esophagogastric cancer (AEGC).
 
Volker Heinemann
Research Funding - Nordic Group
 
Radka Obermannova
No Relationships to Disclose
 
Eugen Kubala
Consulting or Advisory Role - Amgen; Bayer; Roche
 
Bohuslav Melichar
No Relationships to Disclose
 
Rolf Mahlberg
Consulting or Advisory Role - Boehringer Ingelheim; Taiho Pharmaceutical
Travel, Accommodations, Expenses - Merck; Novartis
 
Arndt Weinmann
Employment - University Medical Hospital Mainz
Consulting or Advisory Role - Bayer
Speakers' Bureau - Bayer
Travel, Accommodations, Expenses - Bayer
 
Paul Scigalla
Consulting or Advisory Role - Taiho Pharmaceutical
Travel, Accommodations, Expenses - Taiho Pharmaceutical
 
Marietta Tesarova
Employment - Prague Clinical Services; Prague Clinical Services (I)
 
Petr Janda
Employment - Prague Clinical Services; Prague Clinical Services (I)
Stock and Other Ownership Interests - Accord Research
 
Fabienne Biville-Hedouin
No Relationships to Disclose
 
Wasat Mansoor
Consulting or Advisory Role - Lilly